Login to Your Account

Regulators receptive to 'transformational therapies'

With clinic in sight, Codiak doubles down with $76.5M series C

By Marie Powers
News Editor

Wednesday, November 29, 2017

Codiak Biosciences Inc. closed a $76.5 million series C, extending its runway in a big way following a combined series A/B that hit $92 million.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription